BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4693613)

  • 1. Studies in multiple myeloma. I. Characteristics by immunoglobulin class.
    Murphy WM; Deodhar SD
    Cleve Clin Q; 1973; 40(1):1-7. PubMed ID: 4693613
    [No Abstract]   [Full Text] [Related]  

  • 2. Gel filtration analysis of multiple myeloma sera.
    Tóth I; Sellei C; Eckhardt S; Hindy I
    Haematologia (Budap); 1973; 7(1):7-16. PubMed ID: 4737470
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
    Fine JM; Rivat C; Lambin P; Ropartz C
    Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulin disturbances and their clinical significance.
    Solomon A; McLaughlin CL
    Med Clin North Am; 1973 Mar; 57(2):499-516. PubMed ID: 4632920
    [No Abstract]   [Full Text] [Related]  

  • 5. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.
    Isobe T; Osserman EF
    N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on human secretory immunoglobulin A. 3. J chain.
    Mestecky J; Zikan J; Butler WT; Kulhavy R
    Immunochemistry; 1972 Sep; 9(9):883-90. PubMed ID: 5073880
    [No Abstract]   [Full Text] [Related]  

  • 8. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
    Conway BP
    Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
    [No Abstract]   [Full Text] [Related]  

  • 9. IgD myeloma L-type. Immunochemical study of the first Brazilian case.
    Ferri RG; Llach HF; Balthazar P; Cobra CJ; de Souza Júnior JA
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):229-32. PubMed ID: 5006006
    [No Abstract]   [Full Text] [Related]  

  • 10. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anatomo-morphological characteristics of different protein types in myelomas (IgG, IgA and Bence Jones)].
    Voĭno-Iasenetskaia OV
    Probl Gematol Pereliv Krovi; 1974 Aug; 19(8):34-6. PubMed ID: 4408561
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver disease in multiple myeloma.
    Thomas FB; Clausen KP; Greenberger NJ
    Arch Intern Med; 1973 Aug; 132(2):195-202. PubMed ID: 4719547
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytology of myeloma cells.
    Hayhoe FG; Neuman Z
    J Clin Pathol; 1976 Oct; 29(10):916-22. PubMed ID: 824323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma with double M-proteins of IgD-lambda and IgA-kappa].
    Maruyama Y; Tanikawa S; Sakamaki H; Yahara Y; Onozawa Y; Hayashi Y; Kawaguchi K; Koike M; Ozawa N; Shimizu M
    Rinsho Ketsueki; 1987 Aug; 28(8):1475-80. PubMed ID: 3430755
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in multiple myeloma. II. Light chains.
    Murphy WM; Deodhar SD
    Cleve Clin Q; 1973; 40(1):9-14. PubMed ID: 4693618
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute phase reactants and clinical stages in multiple myeloma.
    San Miguel J; Vicente V; Battle J; Hernandez F; Lopez Borrasca A
    Neoplasma; 1981; 28(3):333-8. PubMed ID: 7290260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavior of immunoglobulin in monoclonal gammopathies and their classification and pathogenesis.
    Kano T
    Tohoku J Exp Med; 1970 Dec; 102(4):369-401. PubMed ID: 4102668
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma without paraprotein.
    Szücs J
    Haematologia (Budap); 1970; 4(1):97-102. PubMed ID: 5522360
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating appearance of IgD and IgG myeloma protein during treatment.
    Oxelius VA
    Scand J Haematol; 1971; 8(6):439-45. PubMed ID: 5160304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.